Experienced Management Team

Glen Travers

Executive Chairman

25 years experience building healthcare businesses, successfully taken several therapeutics and diagnostics to market, some partnered with major multinational pharmaceutical companies.
Co-founded and built biopharmaceutical company Cortecs to peak $1.2bn value, $0.5bn on departure, company shared royalties with Nobel Laureates for Helicobacter discovery.  Listed company in UK, Nasdaq, Australia.

Dr. Roger New

Chief Scientific Officer & Executive Director

Distinguished scientist with a background in biochemistry and immunology, 30 years of experience in drug delivery.
Devised three new systems for oral delivery of peptides and gained first positive human results with an oral insulin.
Previous head of research at Cortecs & a leading scientist at Biocompatibles.
Inventor of numerous formulation technologies.

Timothy Broke-Smith

Chief Business Officer & Chief Operating Officer

Business/corporate development and operations executive that has completed international outlicensing/partnering deals.
Experience across drug development from early research, IP protection, through manufacturing/CMC, to managing preparation and completion of phase II clinical studies, regulators and audit.
Master’s in Bioscience Enterprise from Cambridge University and Bachelor’s in Biology from Imperial College London.

Dr. Tony Lockett

Consultant Medical Director

MD and microbiologist with over 20 years of experience in medicine and clinical drug development.
Focus on endocrinology and immunology.
Previously roles include CMO of a listed company, senior medical advisor at Covance, advisor to the UK Department of Health.
Actively involved in planning and overseeing over 50 clinical trials, including 14 clinical trials in diabetes and obesity.

Print Print | Sitemap
© 2017, Diabetology Ltd